Searched for
MANDIDEEP
USFDA issues Form-483 with 8 observations to Lupin's drug, API production facilities in Mandideep plantThe USFDA had inspected the Mandideep Unit-1 facility in Madhya Pradesh from November 14, 2022, to November 23, 2022, the Mumbai-based drug...24 Nov, 2022, 05.09 PM IST- USFDA red flags Lupin for significant violations at MP unitThe USFDA said it had inspected the Unit 1 at the Mandideep facility of the company from November 26 to December 4, 2018.04 Oct, 2019, 05.27 PM IST
- Lupin gets warning letter from USFDA for Mandideep facilityShares of Lupin were trading 1.36 per cent lower at Rs 749.15 apiece on BSE.19 Sep, 2019, 11.23 AM IST
- USFDA makes 22 observations post inspection of Lupin's Mandideep facilitiesLupin said the observations are "largely procedural in nature with some gaps identified in the aseptic processing areas of the Cephalospori...05 Dec, 2018, 02.00 PM IST
- Lupin gets EDQM nod for its Mandideep facilityThe inspection was focused on the application for certificate of suitability for the dossier of Cefaclor along with facility inspection for...30 Jul, 2018, 02.30 PM IST
- Madhya Pradesh approves six projects worth Rs 3,285 crore of investmentIt includes a project worth Rs 1,450 crore for modernisation and expansion by Vardhman Textile Limited and the expansion project of Sagar M...17 Jan, 2017, 01.01 PM IST
- Normalcy in operations to be restored soon: Crompton GreavesThe company had earlier announced that it has halted operations at its manufacturing unit at Mandideep in Madhya Pradesh after it was hit b...27 Jul, 2016, 12.24 PM IST
- Lupin recalls over 54K vials of anti-bacterial injection in USThe ongoing voluntary recall is a class III recall and is for the US and Puerto Rico, according to the latest enforcement report on USFDA s...08 Jun, 2016, 05.02 PM IST
- Lupin terms USFDA observations "minor", brokerages say nothing to worry aboutThe company received three observations relating to violation of production norms at manufacturing facilities at Mandideep, Madhya Pradesh ...31 Mar, 2016, 06.39 AM IST
- Lupin shares pull back as co clarifies on US FDA action at MandideepLupin’s clarifications — the second in two days — countered issues raised by IIFL Capital, which had termed the observations as "very serio...31 Mar, 2016, 03.51 AM IST
- Lupin gets 3 observations from USFDA for Mandideep plantHowever, the company said the observations were "minor in nature" and would not lead to any disruption of product supply from the location.29 Mar, 2016, 06.39 PM IST
- Lupin plunges as USFDA issues form 483 for Mandideep unitThis is the biggest intraday fall for the stock since January 2011. The stock is currently trading at a 15-month low. The plant was inspect...29 Mar, 2016, 04.24 PM IST
- Lupin gets 3 observations from USFDA for Mandideep plantHowever, the company said the observations were "minor in nature" and would not lead to any disruption of product supply from the location.29 Mar, 2016, 03.34 PM IST
- Bhilwara Group to invest Rs 245 cr in Mandideep HEG plantLNJ Bhilwara Group plans to invest Rs 245 crore in its Mandideep-based plant near Bhopal to raise production levels from 66,000 MTPA at pre...18 Nov, 2011, 11.25 AM IST
- Lupin gets US FDA nod for anti-depressantDrug maker Lupin has received US Food and Drug Association (FDA) approval for anti-depressant, it said on Wednesday.18 Mar, 2010, 02.05 AM IST
- Lupin plants get USFDA nod; co to sell new productsDrug maker Lupin has received clearance from the US drug regulator for its plant at Mandideep in Madhya Pradesh, allowing the Mumbai-based ...21 Jan, 2010, 02.02 AM IST
- Citi maintains 'buy' on LupinCiti has maintained its 'buy' rating on mid-sized Indian pharma firm Lupin, and raised its target price to Rs 1,415, following the acquisit...03 Oct, 2009, 03.30 AM IST
Load More
